PharmiWeb.com - Global Pharma News & Resources
06-Mar-2019

Abarca Receives PBMI Excellence Award for Care Management Strategies

PALM SPRINGS, Calif., March 6, 2019 /PRNewswire/ -- Abarca, a pharmacy benefit manager (PBM) that is disrupting the industry with an entirely new approach to technology and business practices, today announced that it has received the 2019 Pharmacy Benefit Management Institute (PBMI) Excellence Award for Care Management Strategies for its disaster preparation and recovery program. This response plan, that is rooted in business continuity, employee engagement, and patient safety, was put to the test in the aftermath of Hurricane Maria. 

"Abarca's natural disaster response plan transcends the traditional role of a PBM," said Jane Lutz, Executive Director of PBMI. "Their willingness to go above and beyond for those in need, while maintaining uninterrupted business operations, should serve as an inspiration for other PBMs and technology providers everywhere."

When the category 5 storm made landfall in Puerto Rico in 2017, it devastated many communities that Abarca serves, resulting in serious obstacles for patients in need of medications, among other community health challenges. Abarca launched a multi-faceted response plan to ensure access and continuity for their members, employees, and clients, using tactics that included:

  • Deploying clinical and operational teams to pharmacies across the island to assist in processing claims, ensuring patient adherence, and gathering and disseminating critical information about pharmacy operations
  • Cultivating an internal culture of awareness and preparedness, that includes business continuity training and drills throughout the year
  • Developing and maintaining an online database that provided up-to-date information about pharmacy operations across the island

As a result of their preparation, and highly redundant infrastructure, Abarca experienced zero downtime in their ability to process claims and respond to calls from members, pharmacies, and physicians. And, by adapting its Medication Therapy Management (MTM) program to include in person visits to doctor's offices and patient's homes, Abarca was able to achieve a 5-star Comprehensive Medication Reviews (CMR) completion rate of 87%, on average, despite most patients being without telephone service for nearly 3 months.

"Natural disasters can have a tremendous impact on community health, but Abarca feels that we have a responsibility to relieve that burden as much as possible for our clients and members," said Jason Borschow, President and CEO of Abarca. "By developing a preparedness plan, and continuing to re-evaluate and improve it, disasters don't have to result in catastrophe for the lives that we serve."

About Abarca
Abarca is igniting a revolution in healthcare. It started by redefining pharmacy benefits, but this is just the beginning. It is built on the belief that there is a better way for people and companies to work together, connect with each other and make healthcare awesome for everyone. With smarter technology and a straightforward approach to business, Abarca provides a much better experience and greater value for payers and consumers. For nearly a decade, they have challenged many industry conventions and trampled on a few. So, call them a PBM for discussion purposes, but they are unlike any other company out there. Join the revolution at abarcahealth.com.

About PBMI
The Pharmacy Benefit Management Institute (PBMI) is the nation's leading provider of research and education that informs, advises, and influences the industry on topics related to drug cost management. PBMI offers research, continuing education, and web resources to help all critical stakeholders work better together to optimize the overall value of drug benefit programs. Learn more at www.pbmi.com.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/abarca-receives-pbmi-excellence-award-for-care-management-strategies-300804808.html

SOURCE Abarca

Editor Details

Last Updated: 06-Mar-2019